Quick Answer
Pacira BioSciences, Inc. reported Total Revenue of $726.41 million for the year ending 2025.
- Pacira BioSciences, Inc. showed an increase of +3.6% in Total Revenue from 2024 to 2025.
- This data is from Pacira BioSciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $17.14 million | Q3 2013: $23.26 million | Q4 2013: $33.56 million | Q1 2014: $36.66 million | Q2 2014: $47.17 million | Q3 2014: $52.05 million | Q4 2014: $197.67 million | Q1 2015: $58.32 million | Q2 2015: $59.15 million | Q3 2015: $62.21 million | Q4 2015: $69.32 million | Q1 2016: $65.47 million | Q2 2016: $69.64 million | Q3 2016: $68.36 million | Q4 2016: $72.90 million | Q1 2017: $69.28 million | Q2 2017: $70.93 million | Q3 2017: $67.34 million | Q4 2017: $79.08 million | Q1 2018: $74.61 million | Q2 2018: $84.11 million | Q3 2018: $83.45 million | Q4 2018: $95.12 million | Q1 2019: $91.31 million | Q2 2019: $102.60 million | Q3 2019: $104.69 million | Q4 2019: $122.42 million | Q1 2020: $105.68 million | Q1 2020: $105.68 million | Q2 2020: $75.51 million | Q2 2020: $75.51 million | Q3 2020: $117.48 million | Q3 2020: $117.48 million | Q4 2020: $130.97 million | Q1 2021: $119.03 million | Q2 2021: $135.59 million | Q3 2021: $127.72 million | Q1 2022: $157.99 million | Q2 2022: $169.41 million | Q3 2022: $167.47 million | Q1 2023: $160.34 million | Q2 2023: $169.47 million | Q3 2023: $163.93 million | Q1 2024: $167.12 million | Q2 2024: $178.02 million | Q3 2024: $168.57 million | Q1 2025: $168.92 million | Q2 2025: $181.10 million | Q3 2025: $179.52 million.
- Over the full 19 years of available data (2009 to 2025), Pacira BioSciences, Inc.'s Total Revenue has grown by 4,740.8%.
- Historical annual values: Fiscal year 2025: $726.41 million | Fiscal year 2024: $700.97 million | Fiscal year 2023: $674.98 million | Fiscal year 2022: $666.82 million | Fiscal year 2021: $541.53 million | Fiscal year 2021: $541.53 million | Fiscal year 2020: $429.65 million | Fiscal year 2020: $429.65 million | Fiscal year 2019: $421.03 million | Fiscal year 2018: $337.28 million | Fiscal year 2017: $286.63 million | Fiscal year 2016: $276.37 million | Fiscal year 2015: $249.00 million | Fiscal year 2014: $197.67 million | Fiscal year 2013: $85.55 million | Fiscal year 2012: $39.08 million | Fiscal year 2011: $15.69 million | Fiscal year 2010: $14.56 million | Fiscal year 2009: $15.01 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: